836.2000 -21.30 (-2.48%)
NSE Aug 06, 2025 15:52 PM
Volume: 2.1M
 

logo
Laurus Labs Ltd.
24 Apr 2025
836.20
-2.48%
Motilal Oswal
Laurus Lab (LAURUS) delivered a second consecutive quarter with betterthan-expected performance, led by healthy traction in the Formulation (FDF)/API segment. Despite softer-than-expected performance in the CDMO business during 4QFY25, the quarterly sales run rate continued its uptrend.
Deven Choksey released a Sell report for Laurus Labs Ltd. with a price target of 640.0 on 01 Aug, 2025.
More from Laurus Labs Ltd.
Recommended